对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
ZH
登录
ZH
暴涨分析
/
Athira Pharma Inc.
/
2026-04-21
▲ SURGE
Athira Pharma Inc.
+45.0%
ATHA
NASDAQ
Healthcare
2026-04-21
0.58
收盘价
0.4
前收盘价
+45.00%
涨幅
20.1x
量比
暴涨原因
没有相关新闻。
相关新闻
FDA clears Amphastar rival to Atrovent inhaler, 180-day exclusivity
Stocktitan
2026-02-24
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, I
Gurufocus
2026-03-29
Atossa Therapeutics Files Prospectus For Offering $50M Common Shares - Atossa Therapeutics (NASDAQ:ATOS)
Benzinga
2026-02-20
Aurobindo Pharma Announcements/Notices: Latest Sotck/Share Market Notices/Announcements on Aurobindo Pharma, Aurobindo Pharma Stock Split,Bonus, Rights, Re-Structuring, Dividends, Board Meetings, Quarterly Results, Record Date, Ex-Date, Book Closure on BSE/NSE
Moneycontrol
2026-04-08
Dermata Therapeutics shares are trading higher after the U.S. Patent and Trademark Office issued the company a notice of allowance for a U.S. patent titled "COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS" - Dermata Therapeutics (NASDAQ:DRMA)
Benzinga
2026-03-19
技术分析
没有技术分析数据。
查看股票详情
返回暴涨股列表
Athira Pharma Inc. +45.0% 暴涨分析 (2026-04-21) | Alpha Lenz